AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health
Background Preeclampsia, new‐onset hypertension during pregnancy alongside other organ dysfunction, is the leading cause of mortality for the mother and low birth weight for the baby. Low birth weight contributes to high risk of cardiovascular disorders later in life. Women with preeclampsia have ac...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.031417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850150079563825152 |
|---|---|
| author | Nathan Campbell Evangeline Deer Dylan Solise Denise C. Cornelius Ty Turner Lorena M. Amaral Owen Herrock Ariel Jordan Shivani Shukla Tarek Ibrahim Babbette LaMarca |
| author_facet | Nathan Campbell Evangeline Deer Dylan Solise Denise C. Cornelius Ty Turner Lorena M. Amaral Owen Herrock Ariel Jordan Shivani Shukla Tarek Ibrahim Babbette LaMarca |
| author_sort | Nathan Campbell |
| collection | DOAJ |
| description | Background Preeclampsia, new‐onset hypertension during pregnancy alongside other organ dysfunction, is the leading cause of mortality for the mother and low birth weight for the baby. Low birth weight contributes to high risk of cardiovascular disorders later in life. Women with preeclampsia have activated B cells producing agonistic autoantibodies to AT1‐AA (angiotensin II type I receptor). We hypothesize that rituximab, a B cell‐depleting chemotherapeutic, will deplete maternal B cells in reduced uterine perfusion pressure (RUPP) rats without worsening the effect of placental ischemia on pup growth and survival. Methods and Results To test this hypothesis, the RUPP procedure was performed, and rituximab was continuously infused via miniosmotic pump. Maternal blood and tissues were collected. A separate group of dams were allowed to deliver, pup weights were recorded, and at 4 months of age, tissues were collected from offspring. Immune cells were measured via flow cytometry, and AT1‐AA was quantified using a contraction bioassay. Blood pressure increased in RUPP rats and was normalized with rituximab treatment. RUPP offspring also had increased circulating B cells, cytolytic natural killer cells, and increased circulating AT1‐AA, which were normalized with maternal rituximab treatment. This is the first study to analyze the AT1‐AA in RUPP offspring, which was normalized with rituximab. Conclusions Our findings indicate that perinatal rituximab lowers maternal mean arterial pressure in RUPP rats and improves birth weight, circulating AT1‐AA, and circulating natural killer cells, indicating that rituximab improves adverse fetal outcomes in response to placental ischemia. |
| format | Article |
| id | doaj-art-bc9482f48b3540708e4f48b304e77a8e |
| institution | OA Journals |
| issn | 2047-9980 |
| language | English |
| publishDate | 2024-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| spelling | doaj-art-bc9482f48b3540708e4f48b304e77a8e2025-08-20T02:26:40ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-02-0113410.1161/JAHA.123.031417AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring HealthNathan Campbell0Evangeline Deer1Dylan Solise2Denise C. Cornelius3Ty Turner4Lorena M. Amaral5Owen Herrock6Ariel Jordan7Shivani Shukla8Tarek Ibrahim9Babbette LaMarca10Department of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Obstetrics and Gynecology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSDepartment of Pharmacology & Toxicology University of Mississippi Medical Center Jackson MSBackground Preeclampsia, new‐onset hypertension during pregnancy alongside other organ dysfunction, is the leading cause of mortality for the mother and low birth weight for the baby. Low birth weight contributes to high risk of cardiovascular disorders later in life. Women with preeclampsia have activated B cells producing agonistic autoantibodies to AT1‐AA (angiotensin II type I receptor). We hypothesize that rituximab, a B cell‐depleting chemotherapeutic, will deplete maternal B cells in reduced uterine perfusion pressure (RUPP) rats without worsening the effect of placental ischemia on pup growth and survival. Methods and Results To test this hypothesis, the RUPP procedure was performed, and rituximab was continuously infused via miniosmotic pump. Maternal blood and tissues were collected. A separate group of dams were allowed to deliver, pup weights were recorded, and at 4 months of age, tissues were collected from offspring. Immune cells were measured via flow cytometry, and AT1‐AA was quantified using a contraction bioassay. Blood pressure increased in RUPP rats and was normalized with rituximab treatment. RUPP offspring also had increased circulating B cells, cytolytic natural killer cells, and increased circulating AT1‐AA, which were normalized with maternal rituximab treatment. This is the first study to analyze the AT1‐AA in RUPP offspring, which was normalized with rituximab. Conclusions Our findings indicate that perinatal rituximab lowers maternal mean arterial pressure in RUPP rats and improves birth weight, circulating AT1‐AA, and circulating natural killer cells, indicating that rituximab improves adverse fetal outcomes in response to placental ischemia.https://www.ahajournals.org/doi/10.1161/JAHA.123.031417autoantibodiesimmunologyoffspringpreeclampsia |
| spellingShingle | Nathan Campbell Evangeline Deer Dylan Solise Denise C. Cornelius Ty Turner Lorena M. Amaral Owen Herrock Ariel Jordan Shivani Shukla Tarek Ibrahim Babbette LaMarca AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease autoantibodies immunology offspring preeclampsia |
| title | AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health |
| title_full | AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health |
| title_fullStr | AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health |
| title_full_unstemmed | AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health |
| title_short | AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health |
| title_sort | at1 aa is produced in offspring in response to placental ischemia and is lowered by b cell depletion without compromising overall offspring health |
| topic | autoantibodies immunology offspring preeclampsia |
| url | https://www.ahajournals.org/doi/10.1161/JAHA.123.031417 |
| work_keys_str_mv | AT nathancampbell at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT evangelinedeer at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT dylansolise at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT deniseccornelius at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT tyturner at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT lorenamamaral at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT owenherrock at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT arieljordan at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT shivanishukla at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT tarekibrahim at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth AT babbettelamarca at1aaisproducedinoffspringinresponsetoplacentalischemiaandisloweredbybcelldepletionwithoutcompromisingoveralloffspringhealth |